Musculoskeletal Disorders (1.00)
|
|
|
All musculoskeletal disorders except amputation of both extremities at or above the wrists, hemipelvectomy, or hip disarticulation
|
04/02/2021
|
We so extensively revised the musculoskeletal listings in 2021 that while they are not, in general, less restrictive than the prior listings, the issues are different and include the use of different functional criteria to indicate listing-level severity.
If the prior claim was denied before 04/02/2021, prepare a new determination for all subsequent claims involving a musculoskeletal impairment other than amputation of both upper extremities at or above the wrists, hemipelvectomy, or hip disarticulation.
|
Special Senses and Speech (2.00)
|
|
|
All hearing impairments
|
08/02/10
|
We revised the listings for hearing impairments by removing the requirement for testing with hearing aids and replacing listings 2.08 and 102.08 with new listings 2.10 and 102.10, respectively.
If the prior claim was denied before 08/02/10, prepare a new substantive determination for all subsequent claims involving hearing loss.
|
Vision
|
04/29/13
|
If the prior claim was denied before 04/29/2013, prepare a new substantive determination for all subsequent claims involving vision.
|
Respiratory Disorders (3.00)
|
|
|
All respiratory disorders
|
10/07/16
|
We revised the listings for respiratory disorders. While the listings are not, in general, less restrictive, we added new criteria.
If the prior claim was denied before 10/07/16, prepare a new substantive determination for any subsequent claim involving a respiratory impairment.
|
Cardiovascular System(4.00)
|
|
|
All cardiovascular disorders
|
02/10/94
|
We revised the cardiovascular listings so extensively that, while they are not, in general, less restrictive, the issues are different.
If the prior claim was denied before 02/10/94, prepare a new determination for all subsequent claims involving a cardiovascular impairment.
|
Cardiovascular disorders: chronic heart failure; ischemic heart disease; peripheral arterial disease
|
04/13/06
|
We revised the adult listings for chronic heart failure (4.02), ischemic heart disease (4.04), and peripheral arterial disease (4.12). While the listings are not, in general, less restrictive, we added new criteria or revised existing criteria to reflect technological improvements.
If the prior claim was denied before 04/13/06, prepare a new substantive determination for all subsequent claims involving chronic heart failure, ischemic heart disease, or peripheral arterial disease.
|
Digestive Disorders (5.00)
|
|
|
All digestive disorders
|
10/06/23
|
We so extensively revised the digestive disorders listings in 2023 that, while they are not, in general, less restrictive than the prior listings, we added new criteria or revised existing criteria to reflect technological improvements.
If the prior claim was denied before 10/06/23, prepare a new substantive determination for all subsequent claims involving any digestive disorder.
|
Hematological Disorders (7.00)
|
|
|
All hematological disorders
|
05/18/15
|
We so extensively revised the hematological disorders listings in 2015 that, while they are not, in general, less restrictive than the prior listings, the issues are different and include the use of functional criteria to indicate listing-level severity.
If the prior claim was denied before 05/18/15, prepare a new determination for all subsequent claims involving a hematological disorder impairment.
|
Skin Disorders (8.00)
|
|
|
All skin disorders except for Xeroderma Pigmentosum
|
10/06/23
|
We so extensively revised the skin disorders listings in 2023 that, while they are not, in general, less restrictive than the prior listings, the issues are different and include the use of different functional criteria to indicate listing-level severity.
If the prior claim was denied before 10/06/23, prepare a new substantive determination for all subsequent claims involving skin disorders other than Xeroderma Pigmentosum.
|
Congenital Disorders That Affect Multiple Body Systems (10.00)
|
|
|
Non-mosaic Down syndrome in an individual age 18 or older
|
6/19/00
|
We added listing 10.06 for non-mosaic Down syndrome.
If the prior claim was denied before 06/19/00, prepare a substantive determination for all subsequent claims involving an individual age 18 or older with non-mosaic Down syndrome.
|
Neurological Disorders (11.00)
|
|
|
Amyotrophic lateral sclerosis (ALS)
|
08/28/03
|
We revised the listing criteria for evaluating ALS under listing 11.10. We will find disability with medical evidence showing that the claimant has ALS.
If the prior claim was denied before 08/28/03, prepare a new substantive determination for all subsequent claims involving ALS.
|
All neurological disorders except for ALS
|
09/29/16
|
We comprehensively revised the listings for evaluating neurological disorders. We added new listings, removed 3 listings and included new functional criteria for most listings.
If the prior claim was denied before 09/29/16, prepare a new substantive determination for all subsequent claims involving a neurological disorder other than ALS.
|
Mental Disorders (12.00)
|
|
|
Mental Disorders
|
01/17/17
|
We extensively revised the mental disorders listings. While these listings are not, in general, less restrictive, we extensively revised the areas of mental functioning considered in the severity criteria.
If the prior claim was denied before 01/17/17, prepare a new substantive determination for all subsequent claims involving a mental disorder.
|
Cancer (13.00)
|
|
|
Malignant neoplastic disease of the esophagus
|
01/06/86
|
We revised the listing for evaluating tumors located in the lower half of the esophagus (13.16) to remove the requirement for metastatic disease.
If the prior claim was denied before 01/06/86, prepare substantive determination on subsequent claim involving a tumor located in the lower half of esophagus if the prior claim was denied before 01/06/86.
|
Malignant neoplastic disease of the gallbladder
|
01/06/86
|
We revised the criteria for evaluation of carcinoma of the bile ducts to require less extension of the tumors. This change is less restrictive.
If the prior claim was denied before 01/06/86, prepare a substantive determination on the subsequent claim involving carcinoma of the bile ducts if the prior claim was denied before 01/06/86.
|
Malignant neoplastic disease of the penis
|
01/06/86
|
We added new listings to provide standards for tumors of the penis and vulva. (The listing for tumors of the penis was 13.29 from 01/06/86 to 07/08/04. It was renumbered to 13.26 beginning 07/09/04.)
If the prior claim was denied before 01/06/86, prepare a substantive determination on the subsequent claim involving tumors of the penis.
|
• Malignant neoplastic disease of: soft tissue of the head and neck; skin; breast; skeletal system; lungs; small intestine; kidneys, adrenals, or ureters; female genital tract
• Malignant neoplastic disease treated by bone marrow or stem cell transplantation
• Primary site unknown after appropriate search
|
12/15/04
|
We revised the listings for these disorders (13.02C, 13.02E, 13.03A, 13.03B2, 13.06, 13.07, 13.10A, 13.11D, 13.14A, 13.17A, 13.21A, 13.23, 13.27, and 13.28). While these listings are not, in general, less restrictive, we added criteria to recognize the length and debilitating effects of treatment for some malignancies. We also:
• added criteria for other types of tumors that have a similar prognosis as those already in the listings;
• revised the criteria for multiple myeloma to clarify that this listing includes all listing-level manifestations of the disease; and
• added criteria for tumors for which the site of origin cannot be determined.
If the prior claim was denied before 12/15/04, prepare a new substantive determination for all subsequent claims involving these malignant neoplastic diseases.
|
Malignant neoplastic diseases of: skin; thyroid gland; breast; lungs; female genital tract
|
11/5/09
|
We have revised the listings for these disorders (13.03B, 13.09C, 13.10B, 13.14C, 13.23C). While these listings may not, in general, be less restrictive, we added criteria to recognize the length and debilitating effects of treatment for some malignancies. We also added criteria for evaluating malignant neoplastic diseases of the skin, thyroid gland, and breast.
If the prior claim was denied before 11/5/09, prepare a new substantive determination for all subsequent claims involving these malignant neoplastic diseases.
|
Cancer
|
07/20/15
|
We have revised the listings and added some new listings for these disorders (13.02, 13.03, 13.05, 13.06, 13.10, 13.12, 13.13, 13.15, 13.16, 13.17, 13.18, 13.20, 13.22, 13.23, 13.24, 13.29). While these listings may not, in general, be less restrictive, we added criteria to recognize the unfavorable prognoses and length and debilitating effects of treatment for some malignancies.
If the prior claim was denied before07/20/15, prepare a new substantive determination for all subsequent claims involving these malignant neoplastic diseases.
|
Immune System Disorders (14.00)
|
|
|
All immune system disorders except human immunodeficiency virus (HIV) infection, systemic sclerosis, polymyositis and dermatomysitis, and inflamatory arthritis
|
06/16/08
|
We revised the listings for these disorders by either making them less restrictive or making major changes that result in the listing criteria being significantly different. For example, in some listings, we added functional criteria to indicate listing-level severity.
If the prior claim was denied before 06/16/08, prepare a new substantive determination for all subsequent claims involving these immune system disorders listings.
|
Human immunodeficiency virus (HIV) Infection
Systemic sclerosis, polymyositis and dermatomyositis, and inflammatory arthritis
|
01/17/17
04/02/2021
|
We revised the listing used to evaluate human immunodeficiency virus (HIV) infection. While the new listing is not, in general, less restrictive, we have made a number of significant changes. We have removed many criteria and added new criteria to reflect medical advances and changes in expected outcomes for individuals with HIV infection.
If the prior claim was denied before 01/17/17, prepare a substantive determination for all subsequent claims involving symptomatic HIV infection.
We replaced the musculoskeletal functional criteria used to indicate listing-level severity in these listings. While they are not, in general,less restrictive, the issues are different.
If the prior claim was denied before 04/02/21, prepare a new determination for all subsequent claims involving systemic sclerosis, polymyositis and dermatomyositis, and inflammatory arthritis |